Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 4.05% is 18% below its 1-year average of 4.92%, near the low end of its 1-year range (4.05%–5.70%).
As of the fiscal period ended Tuesday, June 30, 2026.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
4.05%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
8.75%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-53.73%
vs the sector median at left
Medline Inc.
Market Cap
$29.30B
Return on Invested Capital (ROIC)
4.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$30.00B
Return on Invested Capital (ROIC)
6.94%
TTM Avg
7.96%
3Y Avg
8.07%
5Y Avg
9.18%
Market Cap
$30.63B
Return on Invested Capital (ROIC)
1.34%
TTM Avg
18.13%
3Y Avg
20.89%
5Y Avg
23.01%
Market Cap
$30.85B
Return on Invested Capital (ROIC)
21.63%
TTM Avg
21.87%
3Y Avg
20.30%
5Y Avg
19.27%
Market Cap
$31.38B
Return on Invested Capital (ROIC)
4.28%
TTM Avg
7.71%
3Y Avg
8.64%
5Y Avg
10.90%
Market Cap
$31.61B
Return on Invested Capital (ROIC)
-12.90%
TTM Avg
-4.21%
3Y Avg
-0.54%
5Y Avg
0.75%
Market Cap
$31.95B
Return on Invested Capital (ROIC)
19.18%
TTM Avg
19.41%
3Y Avg
18.01%
5Y Avg
17.23%
Market Cap
$31.99B
Return on Invested Capital (ROIC)
21.71%
TTM Avg
13.47%
3Y Avg
11.13%
5Y Avg
9.67%
Market Cap
$26.37B
Return on Invested Capital (ROIC)
38.57%
TTM Avg
38.26%
3Y Avg
37.51%
5Y Avg
36.01%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medline Inc. (MDLN) | $29.30B | 4.05% | N/A | N/A | N/A |
| GE HealthCare Technologies Inc. (GEHC)vs › | $30.00B | 6.94% | 7.96% | 8.07% | 9.18% |
| Waters Corporation (WAT)vs › | $30.63B | 1.34% | 18.13% | 20.89% | 23.01% |
| Zoetis Inc. (ZTS)vs › | $30.85B | 21.63% | 21.87% | 20.30% | 19.27% |
| Biogen Inc. (BIIB)vs › | $31.38B | 4.28% | 7.71% | 8.64% | 10.90% |
| Centene Corp. (CNC)vs › | $31.61B | -12.90% | -4.21% | -0.54% | 0.75% |
| ResMed Inc. (RMD)vs › | $31.95B | 19.18% | 19.41% | 18.01% | 17.23% |
| DexCom, Inc. (DXCM)vs › | $31.99B | 21.71% | 13.47% | 11.13% | 9.67% |
| Mettler-Toledo International Inc. (MTD)vs › | $26.37B | 38.57% | 38.26% | 37.51% | 36.01% |
| Labcorp Holdings Inc. (LH)vs › | $26.30B | 8.02% | 6.33% | 5.68% | 7.63% |
ROIC
4.0%
ROE
6.0%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | 4.05% |
| 2026-03-31 | 5.01% |
| 2025-12-31 | 5.70% |
